After 19 years at the US National Institute of Neurological Disorders and Stroke (NINDS), Story Landis retired last month. During her time there, she was struck by a transformation of neurological research on many fronts, including the discovery of disease-linked genes and the development of induced pluripotent stem cell models of disease. But a recent study of NINDS grants shows that funding of basic neurological research has also declined during this time, putting future advances at risk. Landis tells Asher Mullard about how she has worked to put the NINDS back on track before stepping down.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Story Landis. Nat Rev Drug Discov 13, 718–719 (2014). https://doi.org/10.1038/nrd4454
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4454
This article is cited by
-
A plan for sustainable funding for US biomedical research
Nature Reviews Drug Discovery (2015)
